Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 55 Neoplasm Metastasis 3 Stage II Prostate Adenocarcinoma 1 Sleep Initiation and Maintenance Disorders 1 Salivary Gland Neoplasms 1 Prostate Cancer Metastatic Disease 1 Prostate Cancer Metastatic 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castrate-sensitive Prostate Cancer 1 Low Risk Prostate Cancer 1 Fatigue 1 Depression 1 Castration Levels of Testosterone 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Low Risk Prostate Cancer × apalutamide × 1 year × Clear all

NCT03088124 2026-03-20

PC-ARN

Institut Paoli-Calmettes

Phase 2 Completed

Low Risk Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡